Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MENS

Jyong Biotech Ltd

Jun 17 • 04:00PM ET

10.11

Dollar change +2.61
Percentage change 34.80	%

Healthcare • Biotechnology • Taiwan • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	71.57M	Perf Week	-
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-0.49	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	- - -	Perf YTD	-
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROIC	-	52W High	-	Beta	-
Dividend TTM	-	Quick Ratio	0.02	Sales past 5Y	-	Gross Margin	-	52W Low	-	ATR (14)	12.36
Dividend Ex-Date	-	Current Ratio	0.02	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	- -
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / No	LT Debt/Eq	-	EPS Q/Q	-	Payout	-	Rel Volume	-	Prev Close	7.50
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	-	Price	10.11
SMA20	0.00%	SMA50	0.00%	SMA200	0.00%	Trades		Volume	1,444,396	Change	34.80%

Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MENS

Jyong Biotech Ltd

Upgrade your FINVIZ experience